Hemo Organic Ltd Approves Unaudited Quarterly Financial Results for Q1 2026
Hemo Organic Limited has approved the unaudited financial results for the quarter ended June 30, 2026. The Board of Directors reviewed these results at a meeting held on July 15, 2026.The company's results were subjected to a limited review by an Independent Auditor in compliance with applicable standards for interim financial reporting. These unaudited statements reflect the performance and comprehensive income generated during the quarter, alongside the status of other ongoing business transactions.
The statement of standalone unaudited results for the quarter ended June 30, 2026, reflects a loss from continuing operations for the period.
Key financial highlights from the standalone results (figures in Rs. Lakh) are presented below:
| Financial Metric | Quarter Ended 30-06-2026 (Unaudited) | Quarter Ended 31-03-2026 (Audited) | Year Ended 30-06-2025 (Audited) |
|---|---|---|---|
| Total Income | 92.70 | 0.19 | 93.10 |
| Expenses | (29.01) | 31.14 | 2.13 |
| Profit/(Loss) before tax | (7.42) | (29.69) | (11.45) |
| Total Tax Expense | (50.57) | (8.57) | (77.81) |
| Profit/(Loss) for the period from continuing operations | (7.42) | N/A | N/A |
| Total Comprehensive Income for the period | 346.59 | 346.59 | N/A |
The results were reviewed by the Audit Committee and subsequently approved by the Board of Directors during their meeting on July 15, 2026. The company also took note of opportunities to transact other businesses as per the agenda circulated for the board meeting.
Stock Price Movement
Hemo Organic Ltd finished Tuesday strongly, settling at ₹24.42, marking a solid gain of 4.99%. The shares remained completely flat throughout the trading day, as the high and low were both locked precisely at ₹24.42.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.